Scleroderma is an autoimmune disease that causes the skin and internal organs to harden.

The Scleroderma Center at BMC is recognized internationally as a leader in scleroderma, and is the largest scleroderma program in New England. We offer the latest diagnostic and therapeutic measures available. Physicians take a multidisciplinary approach for diagnosis and treatment, working with specialists in cardiology, pulmonology, dermatology, gastroenterology, radiology, urology, and others as needed.

Our program is a member of the Scleroderma Clinical Trials Consortium, a leading scleroderma research center. We conduct extensive scleroderma-related research, including looking at the underlying biology of scleroderma and testing medications through clinical trials. Patients may be offered opportunities to participate in research studies.

Expert, individualized patient care is provided by senior physicians (Drs. Trojanowski, York, Bujor) with extensive experience in the care of scleroderma and its many facets. The multidisciplinary care team has partners in Pulmonary, Cardiology, Dermatology, Gastroenterology, Ob/Gyn, Orthopedics (hand specialist), Nutrition, among others, so that you can receive all of your care by specialists with expertise in all aspects of scleroderma. Care is coordinated with your primary physician and with other providers when necessary.

Localized scleroderma (morphea) patients are seen as part of the Dermatology-Rheumatology clinic at BMC.  Patients can be seen by both specialties on the same day to maximize both convenience and communication between providers, which leads to better outcomes.